Chromosomal anomalies in two coexistent myeloproliferative disorders

Cancer Genetics and Cytogenetics

Volumn 145, Issue 2, 2003, Pages 172-175

  Ganti, Apar Kishor ^a   Potti, Anil ^a   Mehdi, Syed A ^b  

^a UND School of Medicine & Health Sciences Southeast Campus   (United States)

^b Fargo VA Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BCR ABL PROTEIN; ERYTHROPOIETIN; IMATINIB;

ABDOMEN; ADULT; ARTICLE; BATH; BONE MARROW BIOPSY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER REGRESSION; CASE REPORT; CHROMOSOME 19; CHROMOSOME 20; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION; CHRONIC MYELOID LEUKEMIA; CLINICAL EXAMINATION; CLINICAL FEATURE; CYTOGENETICS; DIAGNOSTIC PROCEDURE; DISEASE COURSE; FATIGUE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; HEMATOLOGY; HUMAN; HUMAN TISSUE; KARYOTYPE; LABORATORY TEST; LEUKOCYTE COUNT; MALE; MOLECULAR DYNAMICS; MYELOPROLIFERATIVE DISORDER; PARTIAL TRISOMY 9; PHILADELPHIA 1 CHROMOSOME; PHLEBOTOMY; PHYSICAL EXAMINATION; POLYCYTHEMIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PRURITUS; SCORING SYSTEM; ULTRASOUND;

EID: 0042664105     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(03)00095-5     Document Type: Article

References (14)

1. Wurster-Hill D.H., McIntyre O.R. Chromosome studies in polycythemia vera. Virchows Arch B Cell Pathol. 29:1978 Nov 17;39-44.
2. Najean Y., Deschamps A., Dresch C., Daniel M.T., Rain J.D., Arrago J.P. Acute leukemia and myelodysplasia in polycythemia vera: a clinical study with long-term follow-up. Cancer. 61:1988;89-95.
3. Hoppin E.C., Lewis J.P. Polycythemia rubra vera progressing to Ph1-positive chronic myelogenous leukemia. Ann Intern Med. 83:1975;820-823.
4. Haq A.U. Transformation of polycythemia vera to Ph-positive chronic myelogenous leukemia. Am J Hematol. 35:(2):1990;110-113.
5. Kemp N.H., Stafford J.L., Tanner R. Chromosome studies during early and terminal chronic myeloid leukaemia. Br Med J. 1:1964;1010-1014.
6. Koulischer L., Fruhling J., Henry J. [Cytogenetic findings in Vaquez' disease.] In French. Eur J Cancer. 3:1967;193-201.
7. Diez-Martin J.L., Graham D.L., Petitt R.M., Dewald G.W. Chromosome studies in 104 patients with polycythemia vera. Mayo Clin Proc. 66:1991;287-299.
8. Butcher C., D'Andrea R.J. Molecular aspects of polycythemia vera. (review) Int J Mol Med. 6:2000;243-252.
9. Westwood N.B., Gruszka-Westwood A.M., Pearson C.E., Delord C.F., Green A.R., Huntly B.J., Lakhani A., McMullin M.F., Pearson T.C. The incidences of trisomy 8, trisomy 9 and D20S108 deletion in polycythaemia vera: an analysis of blood granulocytes using interphase fluorescence in situ hybridization. Br J Haematol. 110:2000;839-846.
10. Testa J.R., Kanofsky J.R., Rowley J.D., Baron J.M., Vardiman J.W. Karyotypic patterns and their clinical significance in polycythemia vera. Am J Hematol. 11:1981;29-45.
11. Berger R., Bernheim A., Le Coniat M., Vecchione D., Flandrin G., Dresch C., Najean Y. Chromosome studies in polycythemia vera patients. Cancer Genet Cytogenet. 12:1984;217-223.
12. Bumm T., Mueller C., Al-Ali H.K., Krohn K., Shepherd P., Schmidt E., Leiblein S., Franke C., Hennig E., Friedrich T., Krahl R., Niederwieser D., Deininger M.W. Emergence of clonal cytogenetic abnormalities in Ph- cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority. Blood. 101:2003;1941-1949.
13. Braziel R.M., Launder T.M., Druker B.J., Olson S.B., Magenis E., Mauro M.J., Sawyers C.L., Paquette R.L., O'Dwyer M.E. Hematopathologic and cytogenetic findings in imatinib mesylate-treated chronic myelogenous leukemia patients: 14 months' experience. Blood. 100:2002;435-441.
14. Goldberg S.L., Madan R.A., Rowley S.D., Pecora A.L., Hsu J.W., Tantravahi R. Myelodysplastic subclones in chronic myeloid leukemia: implications for imatinib mesylate therapy. Blood. 101:2003;781.